Compare TMCI & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMCI | ARQQ |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.6M | 289.8M |
| IPO Year | 2021 | 2021 |
| Metric | TMCI | ARQQ |
|---|---|---|
| Price | $4.34 | $21.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.77 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 390.8K | 264.2K |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $212,690,000.00 | N/A |
| Revenue This Year | N/A | $381.13 |
| Revenue Next Year | $8.18 | $212.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.17 | $11.52 |
| 52 Week High | $7.78 | $62.00 |
| Indicator | TMCI | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 51.78 |
| Support Level | $3.84 | $12.04 |
| Resistance Level | $4.67 | $30.46 |
| Average True Range (ATR) | 0.34 | 1.72 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 8.35 | 45.17 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.